Intec Pharma Ltd buy tamam
Start price
21.06.18
/
50%
?3.92
Target price
04.11.19
€11.73
Performance (%)
0.00%
End price
04.11.19
-
Summary
This prediction ended on 04.11.19 with a price of -. The BUY prediction by tamam closed unchanged from the start price. tamam has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Intec Pharma Ltd | - | - | - | - |
iShares Core DAX® | 1.280% | 1.027% | 11.234% | 16.273% |
iShares Nasdaq 100 | -2.457% | -4.650% | 23.181% | 39.418% |
iShares Nikkei 225® | -2.006% | -2.091% | 6.745% | 6.545% |
iShares S&P 500 | -0.662% | -1.246% | 22.521% | 40.218% |
Comments by tamam for this prediction
In the thread Intec Pharma Ltd diskutieren
Intec , a good time to go ¨bottom-fishing¨
As for future catalysts of note, the principal one to look forward to is top-line data from the phase 3 program for AP-CD/LD by the middle of next year. The fact that over 80% of patients who finished the double-blind portion of the trial have opted in to the extension study also bodes well (to a degree).
Es gibt keinen Handelsplatz